Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144M Buy
846,606
+107,256
+15% +$18.5M 0.66% 50
2026
Q1
$125M Sell
739,350
-12,423
-2% -$2.38M 0.63% 50
2025
Q4
$141M Sell
751,773
-12,413
-2% -$2.34M 0.72% 45
2025
Q3
$157M Sell
764,186
-20,421
-3% -$4.36M 0.78% 41
2025
Q2
$175M Sell
784,607
-42,608
-5% -$9.17M 0.88% 29
2025
Q1
$170M Sell
827,215
-18,589
-2% -$3.7M 0.87% 32
2024
Q4
$155M Buy
845,804
+6,784
+0.8% +$1.43M 0.82% 37
2024
Q3
$173M Sell
839,020
-12,824
-2% -$2.47M 0.89% 31
2024
Q2
$149M Buy
851,844
+14,160
+2% +$2.42M 0.83% 36
2024
Q1
$144M Buy
837,684
+1,080
+0.1% +$166K 0.8% 40
2023
Q4
$126M Sell
836,604
-21,648
-3% -$2.9M 0.76% 42
2023
Q3
$103M Buy
858,252
+240
+0% +$29.9K 0.66% 46
2023
Q2
$107M Sell
858,012
-1,880
-0.2% -$221K 0.65% 45
2023
Q1
$99.5M Buy
859,892
+7,128
+0.8% +$786K 0.54% 58
2022
Q4
$96.3M Buy
852,764
+31,872
+4% +$3.45M 0.6% 51
2022
Q3
$79.7M Sell
820,892
-17,760
-2% -$1.81M 0.53% 53
2022
Q2
$78.3M Buy
838,652
+78,980
+10% +$7.7M 0.52% 52
2022
Q1
$80.8M Sell
759,672
-109,520
-13% -$10.7M 0.59% 48
2021
Q4
$96.3M Sell
869,192
-7,168
-0.8% -$772K 0.54% 50
2021
Q3
$83.4M Sell
876,360
-37,364
-4% -$3.66M 0.51% 53
2021
Q2
$87.3M Sell
913,724
-58,596
-6% -$5.19M 0.53% 51
2021
Q1
$83M Sell
972,320
-22,860
-2% -$1.93M 0.53% 49
2020
Q4
$87.9M Sell
995,180
-12,952
-1% -$1.12M 0.56% 47
2020
Q3
$83.9M Sell
1,008,132
-19,044
-2% -$1.47M 0.59% 45
2020
Q2
$68.4M Buy
1,027,176
+2,344
+0.2% +$136K 0.51% 47
2020
Q1
$44.4M Sell
1,024,832
-12,804
-1% -$837K 0.39% 54
2019
Q4
$69.8M Sell
1,037,636
-8,224
-0.8% -$541K 0.48% 52
2019
Q3
$70.1M Sell
1,045,860
-31,336
-3% -$2.01M 0.51% 53
2019
Q2
$63.9M Sell
1,077,196
-29,528
-3% -$1.63M 0.47% 55
2019
Q1
$55.9M Sell
1,106,724
-6,112
-0.5% -$296K 0.51% 53
2018
Q4
$46.7M Buy
1,112,836
+282,388
+34% +$12.6M 0.5% 54
2018
Q3
$41.1M Sell
830,448
-286,260
-26% -$14.8M 0.53% 53
2018
Q2
$51.7M Sell
1,116,708
-4,060
-0.4% -$183K 0.54% 49
2018
Q1
$47.8M Sell
1,120,768
-8,580
-0.8% -$356K 0.53% 54
2017
Q4
$44M Sell
1,129,348
-32,084
-3% -$1.22M 0.45% 56
2017
Q3
$41.9M Sell
1,161,432
-28,860
-2% -$961K 0.46% 56
2017
Q2
$37.5M Sell
1,190,292
-8,020
-0.7% -$249K 0.43% 58
2017
Q1
$37.9M Sell
1,198,312
-5,380
-0.4% -$159K 0.44% 61
2016
Q4
$34.8M Buy
1,203,692
+17,364
+1% +$488K 0.42% 60
2016
Q3
$33.4M Buy
1,186,328
+6,204
+0.5% +$170K 0.4% 65
2016
Q2
$29M Buy
1,180,124
+24,468
+2% +$563K 0.38% 72
2016
Q1
$25.9M Buy
1,155,656
+277,804
+32% +$5.96M 0.34% 72
2015
Q4
$20M Sell
877,852
-68,880
-7% -$1.57M 0.27% 82
2015
Q3
$20.3M Buy
946,732
+44,868
+5% +$963K 0.29% 85
2015
Q2
$19.1M Buy
901,864
+20,404
+2% +$428K 0.26% 84
2015
Q1
$18M Buy
881,460
+107,588
+14% +$2.18M 0.24% 84
2014
Q4
$15.2M Buy
773,872
+595,560
+334% +$10.8M 0.21% 87
2014
Q3
$3.15M Sell
178,312
-3,080
-2% -$50.2K 0.05% 140
2014
Q2
$2.88M Buy
181,392
+3,200
+2% +$48.4K 0.04% 150
2014
Q1
$2.66M Buy
178,192
+1,740
+1% +$25.7K 0.04% 152
2013
Q4
$2.63M Hold
176,452
0.04% 148
2013
Q3
$2.26M Sell
176,452
-1,776
-1% -$21.5K 0.04% 152
2013
Q2
$2.03M Buy
+178,228
New +$2.01M 0.04% 155

Other funds holding CTAS

Bahl & Gaynor's CTAS Position: Q2 2026 in Review

Bahl & Gaynor increased its Cintas (CTAS) stake by 15% in Q2 2026, buying an estimated $18.5M and bringing the position to 846,606 shares worth $144M. The position accounts for 0.66% of the portfolio, ranked #50.

Bahl & Gaynor first reported a position in CTAS in Q2 2013 and has held it in 53 quarters since. The position peaked at $175M in Q2 2025. 1,426 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Bahl & Gaynor held 846,606 shares of Cintas worth $144M as of Q2 2026.
  • Bahl & Gaynor bought 107,256 Cintas shares in Q2 2026, an estimated $18.5M.
  • Cintas made up 0.66% of Bahl & Gaynor's portfolio in Q2 2026, its #50 holding.
  • Bahl & Gaynor first reported a position in Cintas in Q2 2013 and has held it in 53 quarters since.
  • Bahl & Gaynor's Cintas position peaked at $175M in Q2 2025.
  • 1,426 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.